Product details:
| ISBN13: | 9780443246708 |
| ISBN10: | 044324670X |
| Binding: | Hardback |
| No. of pages: | 240 pages |
| Size: | 228x152 mm |
| Weight: | 450 g |
| Language: | English |
| 685 |
Category:
Alcohol-Associated Liver Disease, An Issue of Clinics in Liver Disease
Series:
The Clinics: Internal Medicine;
28-4;
Publisher: Elsevier
Date of Publication: 8 October 2024
Normal price:
Publisher's listprice:
EUR 91.99
EUR 91.99
Your price:
31 990 (30 466 HUF + 5% VAT )
discount is: 20% (approx 7 998 HUF off)
Discount is valid until: 31 December 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
printed on demand
Can't you provide more accurate information?
Long description:
In this issue of Clinics in Liver Disease, guest editor Dr. Ashwani K. Singal brings his considerable expertise to the topic of Alcohol-Associated Liver Disease. Portal hypertension is often one of the major complications seen in advanced liver disease. Top experts discuss various aspects of alcohol-associated liver disease (ALD), to provide comprehensive coverage on current status, update recent developments especially during the last decade, and highlight clinical and experimental unmet needs for practicing providers and for researchers in the field of ALD.
- Contains 18 relevant, practice-oriented topics including microbiome in ALD; diagnosis of alcoholic use disorder and of ALD; non-invasive tests in assessment of ALD patients; treatment of alcoholic use disorder: behavioral and pharmacological therapies; current medical treatment of ALD: pharmacological and nutrition; liver transplantation in ALD; digital technology and AI in management of ALD; and more.
- Provides in-depth clinical reviews on alcohol-associated liver disease, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Table of Contents:
Epidemiology and Health Care Burden of Alcohol Use Disorder
Epidemiology of Alcohol-Associated Liver Disease Including Increasing Burden in Young Adults and Females Especially Since Covid-19 Pandemic
Alcohol and Metabolic Syndrome Interaction
Alcohol-Associated Liver Diseases: Spectrum, Nomenclature, and Definitions
Alcohol and Hepatocellular Carcinoma
Pathogenesis of Alcohol-Associated Liver Disease
Gut Bacteria in Alcohol-Associated Liver Disease
Beyond the Liver: Neurologic Manifestations of Alcohol Use
Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease
Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease
Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis: Current Status and Future Landscape
Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies
Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease
Integrated Multidisciplinary Care Model to Manage the Dual Pathology of Alcohol Use Disorder and of Liver Disease
Liver Transplantation in Alcohol-Associated Liver Disease: Current Status and Future Landscape
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease
Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease
Epidemiology of Alcohol-Associated Liver Disease Including Increasing Burden in Young Adults and Females Especially Since Covid-19 Pandemic
Alcohol and Metabolic Syndrome Interaction
Alcohol-Associated Liver Diseases: Spectrum, Nomenclature, and Definitions
Alcohol and Hepatocellular Carcinoma
Pathogenesis of Alcohol-Associated Liver Disease
Gut Bacteria in Alcohol-Associated Liver Disease
Beyond the Liver: Neurologic Manifestations of Alcohol Use
Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease
Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease
Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis: Current Status and Future Landscape
Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies
Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease
Integrated Multidisciplinary Care Model to Manage the Dual Pathology of Alcohol Use Disorder and of Liver Disease
Liver Transplantation in Alcohol-Associated Liver Disease: Current Status and Future Landscape
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease
Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease
